Epstein Secrets

median discounts from the restricted stock studies. SUMMARY OF RESTRICTED STOCK STUDIES [SEC Studies (non-reporting OTC companies [Gelman Study [Moroney Study $Maher Study [Trout Study [Standard Research Consultants Study [Silber Study [Management Planning, Inc. Study [FMV Study [Hertzel - Smith Stud

529,017 $63,000 plus: Other current assets 7,773 10,345 21,445 29,551 less:Current liabilities (22,612) (24,663) (42,832) (39,775) plus: Sbartiemi debt 0 0 0 0 DFNWC $23,661 $19,793 57,630 $52,776 as % of annualird revenue 16.3% 28.1% 8.8% 36.5% less: Excess cash 19,1331 (9.078)

median discounts from the restricted stock studies. SUMMARY OF RESTRICTED STOCK STUDIES [SEC Studies (non-reporting OTC companies [Gelman Study [Moroney Study $Maher Study [Trout Study [Standard Research Consultants Study [Silber Study [Management Planning, Inc. Study [FMV Study [Hertzel - Smith Stud

529,017 $63,000 plus: Other current assets 7,773 10,345 21,445 29,551 less:Current liabilities (22,612) (24,663) (42,832) (39,775) plus: Sbartiemi debt 0 0 0 0 DFNWC $23,661 $19,793 57,630 $52,776 as % of annualird revenue 16.3% 28.1% 8.8% 36.5% less: Excess cash 19,1331 (9.078)

median discounts from the restricted stock studies. SUMMARY OF RESTRICTED STOCK STUDIES [SEC Studies (non-reporting OTC companies [Gelman Study [Moroney Study $Maher Study [Trout Study [Standard Research Consultants Study [Silber Study [Management Planning, Inc. Study [FMV Study [Hertzel - Smith Stud

529,017 $63,000 plus: Other current assets 7,773 10,345 21,445 29,551 less:Current liabilities (22,612) (24,663) (42,832) (39,775) plus: Sbartiemi debt 0 0 0 0 DFNWC $23,661 $19,793 57,630 $52,776 as % of annualird revenue 16.3% 28.1% 8.8% 36.5% less: Excess cash 19,1331 (9.078)